US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Terminated

Sunitinib Malate Capsules

Reason Failed Moisture Limits: Water (moisture) content above the approved product specifications.

Teva Pharmaceuticals USA Inc NDC 0093-8199-28 D-0913-2023
Class II · Moderate risk Terminated

Bivalirudin for Injection 250 mg

Reason Presence of Particulate Matter: Particulate matter identified as fiber.

Accord Healthcare, Inc. NDC 16729-275-67 D-0918-2023
Class II · Moderate risk Terminated

Atropine Sulfate Injection

Reason Presence of Particulate Matter: Particulate matter identified as fiber.

Accord Healthcare, Inc. NDC 16729-512-43 D-0917-2023
Class II · Moderate risk Terminated

Losartan Potassium Tablets

Reason Presence of Foreign Substance: Presence of a small piece of blue plastic embedded in the tablet.

Strides Pharma Inc. NDC 64380-933-08 D-0895-2023
Class II · Moderate risk Ongoing

Tizanidine Hydrochloride Tablet 4mg

Reason Failed Stability Specifications

Preferred Pharmaceuticals, Inc. NDC 68788-7781-2 D-0894-2023
Class II · Moderate risk Terminated

Safe Tussin PM Night Time Cough Relief

Reason CGMP Deviations: use of non-food grade lubricant in mixing vessel.

Kramer Laboratories, Inc. D-0943-2023
Class II · Moderate risk Terminated

Safe Tussin DM Cough + Chest Congestion

Reason CGMP Deviations: use of non-food grade lubricant in mixing vessel.

Kramer Laboratories, Inc. D-0942-2023
Class II · Moderate risk Terminated

Tizanidine Tablets

Reason Failed Dissolution Specifications: this repackaged product was recalled by the manufacturer, Dr. Reddy's Laboratories, Inc., due to out of specification results for dissolution.

Amerisource Health Services LLC NDC 68084-645-01 D-0892-2023
Class II · Moderate risk Ongoing

Tizanidine Tablets USP

Reason Failed dissolution specification: Out of specification results observed in 24-month long term stability testing.

Dr Reddy's Laboratories Limited NDC 55111-180-10 D-0923-2023
Class II · Moderate risk Terminated

Tramadol Hydrochloride Tablets

Reason Packaging defect: blister packaging inadequately sealed.

The Harvard Drug Group NDC 0904-7179-61 D-0878-2023
Class II · Moderate risk Ongoing

Dry Eye Relief Lubricant Eye Drops

Reason CGMP Deviations: good manufacturing deficiencies related to a lack of documentation of the fill line.

K.C. Pharmaceuticals, Inc NDC 49035-280-02 D-0898-2023
Class II · Moderate risk Ongoing

Original Eye Drops

Reason CGMP Deviations: good manufacturing deficiencies related to a lack of documentation of the fill line.

K.C. Pharmaceuticals, Inc NDC 49348-037-29 D-0897-2023
Class II · Moderate risk Terminated

Endometrin

Reason cGMP deviations: potential for Microbial Contamination of Non-Sterile Products

Ferring Pharmaceuticals Inc NDC 55566-6500-03 D-0879-2023
Class II · Moderate risk Terminated

StellaLife VEGA Oral Care Gel

Reason cGMP deviations

Homeocare Laboratories, Inc. NDC 69685-112-01 D-0890-2023
Class II · Moderate risk Terminated

StellaLife VEGA Oral Care Gel

Reason cGMP deviations

Homeocare Laboratories, Inc. NDC 69685-102-02 D-0889-2023
Class II · Moderate risk Terminated

StellaLife VEGA Oral Care Spray

Reason cGMP deviations

Homeocare Laboratories, Inc. NDC 69685-101-02 D-0888-2023
Class II · Moderate risk Terminated

StellaLife VEGA Oral Care Rinse

Reason cGMP deviations

Homeocare Laboratories, Inc. NDC 69685-113-16 D-0887-2023
Class II · Moderate risk Terminated

StellaLife VEGA Oral Care Rinse

Reason cGMP deviations

Homeocare Laboratories, Inc. NDC 69685-103-16 D-0886-2023
Class II · Moderate risk Terminated

SnoreStop Naso Spray Bulk

Reason cGMP deviations

Homeocare Laboratories, Inc. NDC 61152-199-99 D-0885-2023
Class II · Moderate risk Terminated

DoloEar Earache Drops

Reason cGMP deviations

Homeocare Laboratories, Inc. NDC 55758-001-15 D-0884-2023
Class II · Moderate risk Terminated

Arnica 7 Cream

Reason cGMP deviations

Homeocare Laboratories, Inc. D-0881-2023